Pfizer rheumatoid arthritis therapy wins FDA approval
Xeljanz can be used as a single treatment regime or as combination therapy with standard methotrexate or any non-biologic disease-modifying antirheumatic drugs (DMARDs). Pfizer chairman and chief executive
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.